TP53 and acute myeloid leukemia: Our panel of AML cell lines covered the majority of morphologic and molecular subtypes including FLT3-ITD and FLT3 wild type, NPM1 mutant and NPM1 wild type as well as TP53 wild type, mutant, and hemizygous cells (Table 1).